Literature DB >> 16023637

Lewy bodies in Parkinson's disease: protectors or perpetrators?

Timothy P Harrower1, Andrew W Michell, Roger A Barker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16023637     DOI： 10.1016/j.expneurol.2005.06.002

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  6 in total

1.  Adsorption of α-synuclein to supported lipid bilayers: positioning and role of electrostatics.

Authors:  Erik Hellstrand; Marie Grey; Marie-Louise Ainalem; John Ankner; V Trevor Forsyth; Giovanna Fragneto; Michael Haertlein; Marie-Therese Dauvergne; Hanna Nilsson; Patrik Brundin; Sara Linse; Tommy Nylander; Emma Sparr
Journal:  ACS Chem Neurosci       Date:  2013-07-25       Impact factor: 4.418

2.  Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease.

Authors:  Tomás González-Hernández; Ignacio Cruz-Muros; Domingo Afonso-Oramas; Josmar Salas-Hernandez; Javier Castro-Hernandez
Journal:  Front Neuroanat       Date:  2010-10-20       Impact factor: 3.856

Review 3.  Long-term effects of ionising radiation on the brain: cause for concern?

Authors:  Stefan J Kempf; Omid Azimzadeh; Michael J Atkinson; Soile Tapio
Journal:  Radiat Environ Biophys       Date:  2012-10-26       Impact factor: 1.925

4.  Move for change part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease.

Authors:  B R Bloem; F Stocchi
Journal:  Eur J Neurol       Date:  2011-10-04       Impact factor: 6.089

5.  Acceleration of α-synuclein aggregation by exosomes.

Authors:  Marie Grey; Christopher J Dunning; Ricardo Gaspar; Carl Grey; Patrik Brundin; Emma Sparr; Sara Linse
Journal:  J Biol Chem       Date:  2014-11-25       Impact factor: 5.157

6.  Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression.

Authors:  Emily N Cronin-Furman; M Kathleen Borland; Kristen E Bergquist; James P Bennett; Patricia A Trimmer
Journal:  Mol Neurodegener       Date:  2013-01-26       Impact factor: 14.195
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.